Prof. Dr. Gabriele Fischer

Director, Addiction Clinic, Center of Public Health and Department of Psychiatry & Psychotherapy, Medical University Vienna, Austria

Christoph U Correll, MD

The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA. Charité – Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.

In this discussion, Professors Christoph Correll and Gabriele Fischer address the complexities of treating patients with cooccurring schizophrenia and substance use disorders. The conversation covers the challenges of managing the comorbidity of these disorders.

Related content

What would be your general recommendations for clinicians treating people with schizophrenia? play_circle Video play_circle
What would be your general recommendations for clinicians treating people with schizophrenia?
09.07.2026 Schizophrenia
What is the aetiology of schizophrenia? play_circle Video play_circle
What is the aetiology of schizophrenia?

Schizophrenia remains one of psychiatry’s most complex disorders due to its multifactorial etiology, involving interacting biological, psychological, and environmental factors.

07.07.2026 Schizophrenia
grid_view Slide Deck Schizophrenia epidemiology and burden cover image
Schizophrenia – Epidemiology and burden
01.07.2026 Schizophrenia